OpenAI 2026 hackathon

MediRemind

Flags missed antenatal visits and logs why mothers drop out — giving clinics real dropout data, not guesswork, to bring them back to care.

Team of 4 · 2 likes · 0 comments

Archive position — measured, not model output

2 likes on Devpost

221 of the 7,856 archived projects have more likes, and 285 share exactly 2 — so this project's #387 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

The company appears to be a healthcare workflow tool for antenatal care in Kenya, built around managing patient dropout from scheduled appointments. The product is described as a system that flags missed visits, logs reasons for dropouts, and enables human-led recovery workflows — not a clinical risk prediction or automation tool.

What changed: The project was extended during an OpenAI hackathon using AI tools (Codex, GPT-5.6) to build a full-stack application including backend logic, patient-facing app, staff portals, and security features. It is currently in pre-pilot phase with no real-world deployment yet.

The single most important open question: Is there a confirmed clinic partner ready to test the system against a real ANC caseload?

This analysis is based entirely on the self-reported description provided by the authors. No independent verification or traction data exists beyond what they state.

Back to contents

What The Product Actually Is

  • The description states that MediRemind is a care-continuity workflow for Kenyan clinics.
  • It focuses on missed antenatal visits, not clinical risk prediction or automation.
  • The system tracks when a mother does not show up for a scheduled visit and ensures that:
    • A past scheduled visit is not treated as a no-show until confirmed by clinic staff.
    • Only confirmed no-shows enter recovery workflows.
    • Recovery includes documented outreach, named human ownership, escalation, and rebooking or outcome confirmation.
  • It does not diagnose, predict clinical risk, or automate patient outcomes.
  • The tool is built using:
    • Frontend: Flutter (patient app), React (staff/public portals)
    • Backend: Django, Django REST Framework
    • Infrastructure: Docker, DigitalOcean, Firebase Cloud Messaging, PostgreSQL, Redis, Vite, GitHub Actions
    • AI tools used in development: Codex, GPT-5.6

Inference: The product is a human-accountability system for tracking and managing patient dropout, not a clinical decision support tool.

Back to contents

Positioning & Claim Evolution

  • The tagline states: “Flags missed antenatal visits and logs why mothers drop out — giving clinics real dropout data, not guesswork, to bring them back to care.”
    • This positions the product as a data-driven accountability mechanism for maternal health.
  • The project write-up emphasizes:
    • Care starts with showing up.
    • Focus on human ownership of dropout events, not automation.
    • A workflow-based approach that documents why patients drop out and how clinics respond.
  • The authors claim:
    • They used AI tools (Codex, GPT-5.6) to guide development during a hackathon.
    • The system includes security hardening, tenant-scoped access, and MFA/passkey protection for operations.
  • The project is described as being in pre-pilot stage, with next steps including:
    • A confirmed clinic partner
    • Africa’s Talking SMS sender ID registration

Inference: The positioning is evolving from a hackathon prototype to a real-world pilot-ready tool, but it has not yet been tested in production.

Back to contents

Target Customer & ICP

  • The description states that the product targets Kenyan clinics.
  • It is designed for use in antenatal care (ANC) settings where mothers are booked for visits.
  • The system supports:
    • Clinic staff managing patient attendance
    • Patient-facing app (via Flutter)
    • Public-facing portals (React)
  • The ICP appears to be:
    • Clinics or maternal health programs in Kenya
    • Staff who manage ANC schedules and follow-up
    • Healthcare providers who want to reduce dropout rates by tracking and re-engaging patients

Not evidenced: No specific clinic names, size of clinics, or number of users are provided.

Back to contents

Business Model & Pricing Evidence

  • The description does not state a business model.
  • There is no mention of pricing, licensing, or monetization strategy.
  • The project is described as being in pre-pilot, with no indication of whether it will be offered as SaaS, a one-time implementation, or a free tool.

Inference: No evidence of a defined revenue model or pricing structure exists.

Back to contents

Technical & Delivery Signals

  • Built using:
    • Backend: Django, Django REST Framework
    • Frontend: Flutter (patient), React (staff/public)
    • Infrastructure: Docker, DigitalOcean, Firebase Cloud Messaging, PostgreSQL, Redis, Vite, GitHub Actions
  • AI tools used in development:
    • Codex with GPT-5.6 for discovery, safety review, implementation, security hardening, QA and release.
  • Features include:
    • End-to-end patient appointment continuity
    • Phone-first recovery workflow with hashed OTPs and revocable sessions
    • Delivery reconciliation distinguishing provider acceptance from confirmed delivery
    • MFA/passkey-protected Operations portal
    • Tenant-scoped reads/writes, consent gates, session/token revocation, hashed recovery material
  • The team used a separate staging environment (DigitalOcean Droplet) with:
    • Isolated database, cache, and secrets from production
    • Fictional example.test data only

Inference: The technical stack is modern and well-structured for a healthcare SaaS product. The use of AI tools in development suggests a rapid prototyping approach.

Back to contents

Traction & Maturity Signals

  • The project is described as being in pre-pilot stage.
  • Next milestone:
    • A confirmed clinic partner
    • Africa’s Talking SMS sender ID registration
  • No real-world deployment or user feedback is mentioned.
  • No revenue, customer base, or usage metrics are provided.

Inference: The product has not yet been tested with real users or in a live environment. It is still in development and testing phase.

Back to contents

Competitive Context

  • The description does not mention any direct competitors.
  • The problem it addresses — missed antenatal visits and dropout management — is common in maternal health systems globally, but no specific competitive landscape is described.
  • The focus on human accountability, dropout logging, and recovery workflows may differentiate it from generic appointment reminder tools.

Inference: No evidence of existing competitors or market positioning against them.

Back to contents

Key Risks & Red Flags

  • The product is in pre-pilot stage with no confirmed clinic partner.
  • No revenue, customers, or traction data are provided — all claims are self-reported.
  • The use of AI tools (Codex, GPT-5.6) for development raises questions about:
    • Whether the system has been independently audited
    • How much of the code was manually reviewed or validated
  • The project is not verified by any third party.
  • No evidence of scalability, integration with existing systems, or long-term sustainability.

Inference: High risk due to lack of real-world testing and unverified claims.

Back to contents

Diligence Questions To Ask The Founders

  1. What is the timeline for securing a confirmed clinic partner?
  2. How will the system be integrated into existing clinic workflows?
  3. Is there any clinical or public health stakeholder feedback on the design or workflow?
  4. What are the specific technical challenges in scaling this to multiple clinics?
  5. Are there any privacy or compliance concerns with handling patient data in this way?
  6. How is the team planning to validate the effectiveness of the recovery workflows?

Back to contents

Investment/Partnership Verdict

  • The project is pre-pilot, not yet deployed.
  • It has a clear problem statement and a well-defined workflow for managing dropout in antenatal care.
  • However, there is no evidence of traction, revenue, or confirmed users.
  • The use of AI tools in development is noted but not validated.
  • The system appears technically sound and well-architected, but its real-world impact remains unproven.

Verdict: Early-stage prototype with potential. Not ready for investment or partnership without a confirmed clinic partner and real-world testing.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.